Storch A - Search Results

1

α-Synuclein in Parkinson's disease: causal or bystander?

Riederer P, Berg D, Casadei N, Cheng F, Classen J, Dresel C, Jost W, Krüger R, Müller T, Reichmann H, Rieß O, Storch A, Strobel S, van Eimeren T, Völker HU, Winkler J, Winklhofer KF, Wüllner U, Zunke F, Monoranu CM. Riederer P, et al. Among authors: storch a. J Neural Transm (Vienna). 2019 Jul;126(7):815-840. doi: 10.1007/s00702-019-02025-9. Epub 2019 Jun 25. J Neural Transm (Vienna). 2019. PMID: 31240402 Review.

2

Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype.

Krüger R, Vieira-Saecker AM, Kuhn W, Berg D, Müller T, Kühnl N, Fuchs GA, Storch A, Hungs M, Woitalla D, Przuntek H, Epplen JT, Schöls L, Riess O. Krüger R, et al. Among authors: storch a. Ann Neurol. 1999 May;45(5):611-7. doi: 10.1002/1531-8249(199905)45:5<611::aid-ana9>3.0.co;2-x. Ann Neurol. 1999. PMID: 10319883

3

Workshop II: "neuroprotection"--the Lugano consensus.

Riederer P, Brücke T, Buhmann C, Müller T, Schwartz A, Storch A, Winner B. Riederer P, et al. Among authors: storch a. J Neurol. 2000 Sep;247 Suppl 4:IV/36-7. doi: 10.1007/pl00007774. J Neurol. 2000. PMID: 11199817 Review.

4

Workshop III: late motor complications of Parkinson's disease.

Jost WH, Berg-Mantkowski A, Baas H, Gemende I, Glass J, Kogan E, Schneider E, Storch A. Jost WH, et al. Among authors: storch a. J Neurol. 2000 Sep;247 Suppl 4:IV/38-9. doi: 10.1007/pl00007775. J Neurol. 2000. PMID: 11199818 Review.

5

Comparison of alpha-dihydroergocryptine and levodopa monotherapy in Parkinson's disease: assessment of changes in DAT binding with [123I]IPT SPECT.

Pöpperl G, Tatsch K, Ruzicka E, Storch A, Gasser T, Schwarz J. Pöpperl G, et al. Among authors: storch a. J Neural Transm (Vienna). 2004 Aug;111(8):1041-52. doi: 10.1007/s00702-004-0147-6. Epub 2004 May 12. J Neural Transm (Vienna). 2004. PMID: 15254792 Clinical Trial.

6

Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration.

Storch A, Ludolph AC, Schwarz J. Storch A, et al. J Neural Transm (Vienna). 2004 Oct;111(10-11):1267-86. doi: 10.1007/s00702-004-0203-2. J Neural Transm (Vienna). 2004. PMID: 15480838 Review.

7

New developments in diagnosis and treatment of Parkinson's disease--from basic science to clinical applications.

Storch A, Hofer A, Krüger R, Schulz JB, Winkler J, Gerlach M. Storch A, et al. J Neurol. 2004 Sep;251 Suppl 6:VI/33-8. doi: 10.1007/s00415-004-1608-4. J Neurol. 2004. PMID: 15675723 Review.

8

Neurotoxic mechanisms of 2,9-dimethyl-beta-carbolinium ion in primary dopaminergic culture.

Hamann J, Rommelspacher H, Storch A, Reichmann H, Gille G. Hamann J, et al. Among authors: storch a. J Neurochem. 2006 Aug;98(4):1185-99. doi: 10.1111/j.1471-4159.2006.03940.x. Epub 2006 Jun 19. J Neurochem. 2006. PMID: 16787411 Free article.

9

Early diagnosis of Parkinson's disease.

Spiegel J, Storch A, Jost WH. Spiegel J, et al. Among authors: storch a. J Neurol. 2006 Aug;253 Suppl 4:IV2-7. doi: 10.1007/s00415-006-4002-6. J Neurol. 2006. PMID: 16944352 Review.

10

Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: a reader-blinded monocenter echocardiography study.

Junghanns S, Fuhrmann JT, Simonis G, Oelwein C, Koch R, Strasser RH, Reichmann H, Storch A. Junghanns S, et al. Among authors: storch a. Mov Disord. 2007 Jan 15;22(2):234-8. doi: 10.1002/mds.21225. Mov Disord. 2007. PMID: 17094087 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

397 results

Search Page